Skip to search boxSkip to navigationSkip to main content

Evaluation of cognitive impairment in elderly population with hypertension from a low-resource setting: Agreement and bias between screening tools

*Corresponding author for this work
Research Output:
Contribution to journal
Article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 35-40 (6 pages)

Journal (Volume, Issue Number)

eNeurologicalSci (Volume 5)

Publication milestones

  • Published - 01/12/2016

Publication status

Published - 01/12/2016

Publication IDs

  • Scopus: 85007193596

Abstract

Introduction The evaluation of cognitive impairment in adulthood merits attention in societies in transition and especially in people with chronic diseases. Screening tools available for clinical practice and epidemiological studies have been designed in high-income but not in resource-constrained settings. The aim of this study was to assess the agreement and bias of three common tools used for screening of cognitive impairment in people with hypertension: the modified Mini-Mental State Examination (MMSE), the Montreal Cognitive Assessment (MoCA), and the Leganés Cognitive Test (LCT). Methods A cross-sectional study enrolling participants with hypertension from a semi-urban area in Peru was performed. The three screening tools for cognitive impairment were applied on three consecutive days. The prevalence of cognitive impairment was calculated for each test. Pearson's correlation coefficients, Bland-Altman plots, and Kappa statistics were used to assess agreement and bias between screening tools. Results We evaluated 139 participants, mean age 76.5 years (SD ± 6.9), 56.1% females. Cognitive impairment was found in 28.1% of individuals using LCT, 63.3% using MMSE, and 100% using MoCA. Correlation coefficients ranged from 0.501 between LCT and MoCA, to 0.698 between MMSE and MoCA. Bland-Altman plots confirmed bias between screening tests. The agreement between MMSE and LCT was 60.4%, between MMSE and MoCA was 63.3%, and between MoCA and LCT was 28.1%. Conclusions Three of the most commonly used screening tests to evaluate cognitive impairment showed major discrepancies in a resource-constrained setting, signaling towards a sorely need to develop and validate appropriate tools.

Funding Details

JJM currently receives, or has received during the planning of this study, further support from the Alliance for Health Policy and Systems Research (HQHSR1206660), Consejo Nacional de Ciencia y Tecnología (CONCYTEC), DFID/MRC/Wellcome Global Health Trials (MR/M007405/1), Fogarty International Center (R21TW009982), Grand Challenges Canada (0335-04), the International Development Research Center Canada (106887, 108167), the Inter-American Institute for Global Change Research (IAI CRN3036), the National Heart, Lung and Blood Institute (5U01HL114180, HHSN268200900028C), the National Institute of Mental Health (1U19MH098780), and the Swiss National Science Foundation (40P740-160366). AB-O is a research training fellow in public health and tropical medicine funded by the Wellcome Trust (103994/Z/14/Z). MAP is supported by a postdoctoral fellowship (2014–2016) of the Peruvian National Council for Science and Technology (Consejo Nacional de Ciencia y Tecnología -CONCYTEC).
FundersFunding numbers
Peruvian National Council for Science and Technology
-
NIMH
1U19MH098780
NHLBI
5U01HL114180, HHSN268200900028C
FIC
R21TW009982
AHPSR
HQHSR1206660
WT
MR/M007405/1, 103994/Z/14/Z
IDRC
108167, 106887
MRC
-
DFID
-
SNF
40P740-160366
CONACYT
-
GCC
0335-04
IAI
IAI CRN3036